1:43 Total patient care: Dr. Daniel DeAngelo | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 14 years ago
2:05 ASH24: Daniel DeAngelo, MD, PhD | Dana-Farber Cancer Institute Dana-Farber Cancer Institute 191 views - 1 year ago
0:42 Dr. Dan DeAngelo discusses new treatment options for older adults with acute lymphoblastic leukemia. Dana-Farber Cancer Institute 6 years ago
1:50 Immunotherapy for reducing the rate of relapsed/refractory ALL VJHemOnc – Video Journal of Hematology & HemOnc 7 years ago
1:10 Avapritinib for advanced systemic mastocytosis: analysis of patient-reported outcomes from EXPLORER VJHemOnc – Video Journal of Hematology & HemOnc 620 views - 7 years ago
1:11 Results and rational behind breakthrough therapy-designated E-selectin antagonist for AML VJHemOnc – Video Journal of Hematology & HemOnc 8 years ago
0:43 Dose optimization of inotuzumab ozogamicin in adult patients with R/R ALL VJHemOnc – Video Journal of Hematology & HemOnc 1 year ago
0:53 Key updates in therapies for acute leukemias from ASH 2018 VJHemOnc – Video Journal of Hematology & HemOnc 7 years ago
1:39 A predictive model for advanced vs indolent systemic mastocytosis based on peripheral blood testing VJHemOnc – Video Journal of Hematology & HemOnc 228 views - 1 year ago
1:25 Updates in adult leukemia treatment from 2018 ASH Annual Meeting Dana-Farber Cancer Institute 185 views - 7 years ago
0:53 Dose optimization portion of the APEX trial investigating bezuclastinib in patients with AdvSM VJHemOnc – Video Journal of Hematology & HemOnc 1 year ago